Literature DB >> 1526170

Nail psoriasis.

E M Farber1, L Nall.   

Abstract

Psoriatic nail involvement is common and accompanies skin lesions on the body surface. The occurrence of nail psoriasis has been reported in up to 50 percent of patients, including children, adults, and the elderly. The characteristics of psoriatic nails are pitting, discoloration, onycholysis, subungual hyperkeratosis, as well as crumbling and grooving of nails and splinter hemorrhages. There is no consistently effective treatment for psoriatic nail involvement; nails are difficult to treat and respond slowly to therapy. Corticosteroids, 5-fluorouracil, systemic agents such as photochemotherapy, oral retinoids, and methotrexate, and nail avulsion are among the therapeutic approaches utilized. We offer suggested measures whereby patients may benefit in the prevention and control of their nail psoriasis.

Entities:  

Mesh:

Year:  1992        PMID: 1526170

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  8 in total

1.  Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.

Authors:  Peter Foley; Kenneth Gordon; Christopher E M Griffiths; Yasmine Wasfi; Bruce Randazzo; Michael Song; Shu Li; Yaung-Kaung Shen; Andrew Blauvelt
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

Review 2.  Psoriasis in children: a guide to its diagnosis and management.

Authors:  J Leman; D Burden
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Comparison of the Objective Severity and the Esthetic Perception of Nail Symptoms in Psoriasis.

Authors:  Júlia Szebényi; Péter Oláh; Rolland Gyulai
Journal:  Skin Appendage Disord       Date:  2022-02-14

4.  Could Psoriatic Arthritis Be Easily Diagnosed from Current Suspicious Physical Findings in the Dermatology Clinic?

Authors:  Jee Woong Choi; Bo Ri Kim; Eunmi Seo; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2017-02-03       Impact factor: 1.444

5.  Toenail Psoriasis during Ustekinumab Therapy: Results and Limitations.

Authors:  Seungkeol Yang; Bo Ri Kim; Minsu Kim; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2021-03-08       Impact factor: 1.444

6.  Nail psoriasis as a severity indicator: results from the PsoReal study.

Authors:  Marc A Radtke; Anna K Langenbruch; Ines Schäfer; Katharina Herberger; Kristian Reich; Matthias Augustin
Journal:  Patient Relat Outcome Meas       Date:  2010-12-22

7.  Measuring disease activity in psoriatic arthritis.

Authors:  Priscilla C H Wong; Ying-Ying Leung; Edmund K Li; Lai-Shan Tam
Journal:  Int J Rheumatol       Date:  2012-12-25

8.  Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy.

Authors:  Su Jin Oh; Jeong Eun Kim; Joo Yeon Ko; Young Suck Ro
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.